Literature DB >> 16854954

Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo.

Elen M de Souza1, Gabriel M Oliveira, David W Boykin, Arvind Kumar, Qiyue Hu, Maria De Nazaré C Soeiro.   

Abstract

OBJECTIVES: Aromatic diamidines have been successfully used to combat a wide range of parasites that cause important human infections. One such compound is furamidine (DB75) and we recently reported that one of its analogues, an N-phenyl analogue (DB569), exhibits higher trypanocidal dose and time-dependent effects against different forms of Trypanosoma cruzi as compared with DB75. Our present aim was to investigate the efficacy of DB569 in a T. cruzi mouse model.
METHODS: The trypanocidal activity of the compound was evaluated by clinical, parasitological, histopathological and biochemical investigations.
RESULTS: Treatment with DB569 significantly reduced cardiac parasitism, partially increased the survival rates of mice and lowered the levels of alanine aminotransferase and creatinine indicating a protective role against renal and hepatic lesions caused by the parasite infection.
CONCLUSIONS: Altogether, the data support the potential effect of this class of compounds against T. cruzi and motivate the screening of new diamidines for efficacy against Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854954     DOI: 10.1093/jac/dkl259

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA.

Authors:  A Daliry; M Q Pires; C F Silva; R S Pacheco; M Munde; C E Stephens; A Kumar; M A Ismail; Z Liu; A A Farahat; S Akay; P Som; Q Hu; D W Boykin; W D Wilson; S L De Castro; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

3.  Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi.

Authors:  A S Da Silva; V C Pimentel; A M Fiorenza; R T França; A A Tonin; J A Jaques; C A M Leal; C B Da Silva; V Morsch; M R C Sschetinger; S T A Lopes; S G Monteiro
Journal:  Ann Trop Med Parasitol       Date:  2011-07

4.  In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi.

Authors:  K Salomão; E M de Souza; S A Carvalho; E F da Silva; C A M Fraga; H S Barbosa; S L de Castro
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

5.  Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.

Authors:  Christopher A Rice; Beatrice L Colon; Mehmet Alp; Hakan Göker; David W Boykin; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

6.  In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.

Authors:  Cristiane França da Silva; Marcos Meuser Batista; Denise da Gama Jaen Batista; Elen Mello de Souza; Patrícia Bernardino da Silva; Gabriel Melo de Oliveira; Andrea Souza Meuser; Abdur-Rafay Shareef; David W Boykin; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

7.  Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes.

Authors:  Amanda M Mathis; Arlene S Bridges; Mohamed A Ismail; Arvind Kumar; Iris Francesconi; Mariappan Anbazhagan; Qiyue Hu; Farial A Tanious; Tanja Wenzler; Janelle Saulter; W David Wilson; Reto Brun; David W Boykin; Richard R Tidwell; James Edwin Hall
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

8.  Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.

Authors:  Cristiane França da Silva; Denise da Gama Jaen Batista; Julianna Siciliano De Araújo; Marcos Meuser Batista; Jessica Lionel; Elen Mello de Souza; Erica Ripoll Hammer; Patricia Bernardino da Silva; Maria De Mieri; Michael Adams; Stefanie Zimmermann; Matthias Hamburger; Reto Brun; Wolfgang Schühly; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

9.  Cellular effects of reversed amidines on Trypanosoma cruzi.

Authors:  C F Silva; M B Meuser; E M De Souza; M N L Meirelles; C E Stephens; P Som; D W Boykin; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

10.  Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Constança Carvalho Britto; Ana Carolina Mondaine Rodrigues; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.